This will be accomplished by providing treatment plan options “in the best interests of the patients” based on results provided by an AI evidence-based decision tree which IMU will help to develop.
Once completed, Q&M will own the rights to the technology. The AI system may also be used as an adjunct training tool which Q&M may use to continue educating its dentists, says the group in a Monday filing.
A prototype of the project is due to roll out in 4Q19.
Shares in Q&M closed flat at 44 cents on Monday.
